In the mean time, overnight in the Delaware federal District courthouse, in essentially the same set of Hep C patent disputes -- the agreed time line to trial was extended. Several key discovery, deposition and other cutoff dates were stretched out. And thus one might reasonably infer that -- depending on the outcome of the ongoing patent trial on the West Coast -- the parties may yet settle out East, avoiding a need for additional trial prep, in Delaware. We shall see.
That's your Friday Merck litigation update.
I'll candidly confess to still being more than a little down in the mouth, post St. Padraich's -- about the prospect of additional/new Ebola viral transmission lines, inside Guinea. I applaud Merck for making vaccine stock available there (likely for free) -- but sure wish we could tamp out the human to human transmission of the virus, en todo -- throughout Africa. Over 11,300 people are dead and gone, due to this now-waning epidemic, Do keep all the people there in your meditations, this weekend. Onward, with a triathalete son training now, in the picturesque Smoky Mountains. . . smile.
No comments:
Post a Comment